[Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
Sixty-seven patients with various intracranial pathologies were studied using Gd-DTPA as a contrast medium applied to MRI. This paramagnetic substance was well tolerated by all patients, and proved particularly useful in improving the diagnosis of extra-axial tumors, in which a rich enhancement was always present. Gd-DTPA allowed a better definition of the tumor outlines, as well as its differentiation from edema, and the demonstration of its relationship to brain parenchyma and cerebral vessels. This was particularly true for meningiomas, which often display poor contrast enhancement at MRI. Even though acoustic neuromas had, as a rule, high signal intensity, Gd-DTPA was useful to precisely recognize the intracanalar part of the tumor. The value of Gd-DTPA was less evident in intra-axial lesions. It proved nonetheless useful in demonstrating the portions of the tumor where, due to alterations in BBB, enhancement was present. This allowed both to characterize the lesion and to perform accurate biopsies.
Bradac
G B
GB
Cattedra di Neuroradiologia, Università, Torino.
Riva
A
A
Berger
T
T
Stura
G
G
Duca
S
S
D001932:Brain Neoplasms / Q000175:diagnosis*; D003287:Contrast Media; D003390:Cranial Nerve Neoplasms / Q000175:diagnosis; D005682:Gadolinium; D019786:Gadolinium DTPA; D005910:Glioma / Q000175:diagnosis*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008577:Meningeal Neoplasms / Q000175:diagnosis*; D008579:Meningioma / Q000175:diagnosis*; D009442:Neurilemmoma / Q000175:diagnosis; D009464:Neuroma, Acoustic / Q000175:diagnosis*; D009942:Organometallic Compounds; D004369:Pentetic Acid; D014276:Trigeminal Nerve
D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA
Il gadolinium-DTPA nella risonanza magnetica. Esperienze cliniche nella patologia intra-cranica.